TFA
RMD icon

Transamerica Financial Advisors’s ResMed RMD Stock Holding History

Transamerica Financial Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.09K Sell
21
-132
-86% -$27.4K ﹤0.01% 1170
2026
Q1 		$34.4K Buy
153
+135
+750% +$33.6K ﹤0.01% 703
2025
Q4 		$4.34K Buy
18
+5
+38% +$1.28K ﹤0.01% 991
2025
Q3 		$3.29K Buy
+13
New +$3.55K ﹤0.01% 949
2023
Q4 		– Sell
-46
Closed -$7K – 651
2023
Q3 		$7K Hold
46
– – ﹤0.01% 344
2023
Q2 		$11K Hold
46
– – ﹤0.01% 309
2023
Q1 		$11K Buy
+46
New +$9.98K ﹤0.01% 318
2013
Q4 		– Sell
-8,462
Closed -$447K – 633
2013
Q3 		$447K Sell
8,462
-7,190
-46% -$349K 0.06% 149
2013
Q2 		$707K Buy
+15,652
New +$743K 0.12% 94

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Transamerica Financial Advisors's RMD Position: Q2 2026 in Review

Transamerica Financial Advisors reduced its ResMed (RMD) stake by 86% in Q2 2026, selling an estimated $27.4K and leaving 21 shares worth $4.09K. The position accounts for ﹤0.01% of the portfolio, ranked #1170.

Transamerica Financial Advisors first reported a position in RMD in Q2 2013 and has held it in 9 quarters since. The position peaked at $707K in Q2 2013. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Transamerica Financial Advisors held 21 shares of ResMed worth $4.09K as of Q2 2026.
  • Transamerica Financial Advisors sold 132 ResMed shares in Q2 2026, an estimated $27.4K.
  • ResMed made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #1170 holding.
  • Transamerica Financial Advisors first reported a position in ResMed in Q2 2013 and has held it in 9 quarters since.
  • Transamerica Financial Advisors's ResMed position peaked at $707K in Q2 2013.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.